Angiotech Pharmaceuticals, Inc.
VANCOUVER, Nov. 8 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced that it plans to exhibit its SharpGuard(TM) product line as well as all of its Sharpoint(TM) brand ophthalmic disposable surgical instruments at the upcoming American Academy of Ophthalmology (AAO) annual meeting.
About the SharpGuard(TM) Guarded Knives Product Line
The SharpGuard(TM) product line is comprised of microsurgical guarded knives for use in ophthalmic surgery. Key features of the SharpGuard(TM) product line include:
- Guarded sheath designed to eliminate or minimize sharps injuries
- Sharpoint(TM) premium quality microsurgical blades manufactured by
proprietary Infinite Edge(TM) technology process
- Ergonomic grip designed for precise control and comfort
- Designed to comply with OSHA bloodborne pathogens regulations
Angiotech will host Booth # 2411 at the AAO annual meeting in New Orleans, LA, taking place from November 10-13, 2007.
About Angiotech
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech , please visit our website at www.angiotech.com.
SHARPGUARD(TM), SHARPOINT(TM) and INFINITE EDGE(TM) are trademarks of
Surgical Specialties Corporation, a wholly-owned subsidiary of Angiotech
Pharmaceuticals, Inc.
(C)2007 Angiotech Pharmaceuticals, Inc. (C)2007 Surgical Specialties
Corporation. All Rights Reserved.
CONTACT: Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, [email protected]